The trade group representing the nation’s top pharmacy benefit managers is redoubling criticism of congressional scrutiny into the industry, taking aim at a House panel for not inviting the organization’s members to testify at a hearing Tuesday.
The Pharmaceutical Care Management Association, whose members include
“Congress’s oversight and ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
